Quotient Sciences

Their innovative approach, agility and flexibility enables us to overcome project challenges and save our customers valuable time - enabling them to bring life-changing medicines to market more rapidly and cost-effectively.They work with big pharma, speciality pharma and biotech companies across the world, from established multinationals to emerging start-ups.

PharMaterials Ltd. engages in the development of preclinical and early phase formulations and manufactures clinical trials materials. The company was founded in 2000 and is based in Reading, United Kingdom. PharMaterials Ltd. was formerly a subsidiary of Pharmaceutics International, Inc. As of November 13, 2017, PharMaterials Ltd. operates as a subsidiary of Quotient Clinical Ltd.

Founded in 2002, QS Pharma specialises in the formulation development and manufacturing of small molecule drug products, and is capable of supporting customer programs through all stages of development and commercialisation. Of particular relevance is QS Pharma’s capability to work with high potency molecules, which is a fast-growing market need.

SeaView Research, Inc. is a clinical research organization based in Miami, Florida, specializing in clinical pharmacology testing and laboratory services for the pharmaceutical industry. Established in 1995, the company conducts a wide range of studies, including pharmacokinetic and pharmacodynamic evaluations, drug interaction studies, and first-in-man trials. It is equipped to perform various types of drug administration, such as oral, topical, and intravenous methods, and offers services related to multiple therapeutic areas, including diabetes, dermatology, and smoking cessation. SeaView Research also studies diverse populations, including healthy volunteers and specific demographic groups like the elderly and postmenopausal women. The organization emphasizes adherence to rigorous protocols while maintaining high standards of quality and timeliness in its research processes. As of 2017, SeaView Research operates as a subsidiary of Quotient Clinical Ltd.